Showing results (641-650 of 671) with videos related to

Sort By:
Pageof 68
Nature Communications|April 28, 2022
Synthetic cells with self-activating optogenetic proteins communicate with natural cellsOmer Adir, Mia R Albalak, Ravit Abel, et al.
Journal of the American Heart Association|September 2, 2017
Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial FibrillationGhanshyam Palamaner Subash Shantha, Amgad Mentias, Chakradhari Inampudi, et al.
Cell|August 1, 2017
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In VivoJoshua A Horwitz, Yotam Bar-On, Ching-Lan Lu, et al.
Circulation|December 8, 2004
Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expressionPhillip A Horwitz, Emily J Tsai, Mary E Putt, et al.
Biotechnology and Bioengineering|February 11, 2019
Challenging the workhorse: Comparative analysis of eukaryotic micro-organisms for expressing monoclonal antibodiesHanxiao Jiang, Andrew A Horwitz, Chapman Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2014
Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditionsLing Lu, Qin Lan, Zhiyuan Li, et al.
Cell|August 19, 2014
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized miceAriel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.
Nature Biomedical Engineering|October 7, 2021
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycinJung Seok Lee, Patrick Han, Rabib Chaudhury, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2011
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trialDavid J Cohen, Tara A Lavelle, Ben Van Hout, et al.
Pageof 68